Document is current
Any future updates will be listed below
-
Authors
Fried, Aneta https://orcid.org/0009-0001-3889-8982
Itterheimova, Karolina https://orcid.org/0009-0004-6578-3365
Moranova, Ludmila https://orcid.org/0000-0003-3117-5535
Bartosik, Martin https://orcid.org/0000-0002-4728-1626
-
Funding
Funding for this research was provided by:
Ministerstvo Školství, Mládeže a Tělovýchovy (CZ.02.01.01/00/22_008/0004644)
Grantová Agentura České Republiky (25-15990S)
Ministerstvo Zdravotnictví Ceské Republiky (00209805)
Agentura Pro Zdravotnický Výzkum České Republiky (NU23J-08-00006)
Masaryk Memorial Cancer Institute
- License Information
-
More Information
Article History
Received: 19 November 2025
Revised: 30 January 2026
Accepted: 17 February 2026
First Online: 5 March 2026
Declarations
: The cervical cancer cell lines HeLa and SiHa, colorectal adenocarcinoma cell line SW620, human melanoma cell line A375, and lung fibroblast cell line MRC-5 and hCMV laboratory strain AD169 and clinical strain Merlin were all purchased from ATCC, USA.
: The authors declare no competing interests.
